GL1X · GenesisL1 explorer

Research workbench

FAD and NADH binding domain of methane monooxygenase reductase from methylococcus capsulatus (bath)

Analyse FAD and NADH binding domain of methane monooxygenase reductase from… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1TVC
Type
protein
Length
250 residues
Chains
1
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Methane monooxygenase component C
EC
1.14.13.25
UniProt
P22868
Ligands
FDA
Pockets
2 · best druggability 0.54

Structure

solution nmr · 1 distinct chain · 21% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMethane monooxygenase component C (EC 1.14.13.25)protein25021% helix, 25% strandP22868

Ligands and binding sites

  • FDA · Dihydroflavine-adenine dinucleotide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11850.540.7932FDA
2950.530.8321empty

Compared structures

  • 1TVC · FAD and NADH binding domain of methane monooxygenase reductase from Methylococcus… · the same entry in another collection · chain A against A, TM-score 1.00
  • P22868 · AlphaFold monomer V2.0 prediction for methane monooxygenase component C (P22868) · a predicted model of the same protein · chain A against A, TM-score 0.75

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.